Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-kB-dependent Signaling Pathway02:26

NF-kB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The atypical IκB factor IκBδ enhances CD8 T cell accumulation and effector functions in solid tumors.

bioRxiv : the preprint server for biology·2026
Same author

Integrated targeted whole-genome and RNA-sequencing analysis of an intronic GNE variant in GNE myopathy.

Human genome variation·2026
Same author

A case of hereditary hemorrhagic telangiectasia with <i>ACVRL1</i> gene variant.

Dermatology reports·2026
Same author

Overcoming Normalcy Bias in Acute Myocardial Infarction: A Case Report of Generative AI as a Behavioral Catalyst for Emergency Care Seeking.

Cureus·2026
Same author

A Case of Multifocal Venous Malformation With Two Somatic Pathogenic Variants in the TEK Gene.

The Journal of dermatology·2025
Same author

A selective RPL15 PROTAC degrader enhances anti-PD-1 immunotherapy in a murine melanoma tumor model.

Oncogene·2025

Related Experiment Video

Updated: Jul 6, 2026

Native Polyacrylamide Gel Electrophoresis Immunoblot Analysis of Endogenous IRF5 Dimerization
08:57

Native Polyacrylamide Gel Electrophoresis Immunoblot Analysis of Endogenous IRF5 Dimerization

Published on: October 6, 2019

KAP1 regulates type I interferon/STAT1-mediated IRF-1 gene expression.

Shinya Kamitani1, Norihiko Ohbayashi, Osamu Ikeda

  • 1Department of Immunology, Graduate School of Pharmaceutical Sciences, Hokkaido University, Kita-Ku Kita 12 Nishi 6, Sapporo 060-0812, Japan.

Biochemical and Biophysical Research Communications
|April 3, 2008
PubMed
Summary

KAP1 represses interferon signaling by binding to STAT1. Reducing KAP1 enhances STAT1-dependent gene expression, revealing KAP1 as a regulator of the IFN/STAT1 pathway.

More Related Videos

A High Resolution Method to Monitor Phosphorylation-dependent Activation of IRF3
11:44

A High Resolution Method to Monitor Phosphorylation-dependent Activation of IRF3

Published on: January 24, 2016

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
10:00

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes

Published on: March 24, 2015

Related Experiment Videos

Last Updated: Jul 6, 2026

Native Polyacrylamide Gel Electrophoresis Immunoblot Analysis of Endogenous IRF5 Dimerization
08:57

Native Polyacrylamide Gel Electrophoresis Immunoblot Analysis of Endogenous IRF5 Dimerization

Published on: October 6, 2019

A High Resolution Method to Monitor Phosphorylation-dependent Activation of IRF3
11:44

A High Resolution Method to Monitor Phosphorylation-dependent Activation of IRF3

Published on: January 24, 2016

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
10:00

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes

Published on: March 24, 2015

Area of Science:

  • Molecular Biology
  • Immunology
  • Gene Regulation

Background:

  • Signal transducers and activators of transcription (STATs) are crucial for cellular processes.
  • KAP1 (KRAB-associated protein 1) is a known co-repressor for transcription factors.
  • Previous work identified KAP1 as a STAT3-binding partner.

Purpose of the Study:

  • To investigate the role of KAP1 in interferon (IFN)/STAT1 signaling.
  • To determine if KAP1 interacts with STAT1.
  • To elucidate KAP1's function in regulating IFN/STAT1-mediated gene expression.

Main Methods:

  • Co-immunoprecipitation to assess protein interactions.
  • Small interfering RNA (siRNA) to reduce KAP1 expression.
  • Quantitative gene expression analysis (e.g., IRF-1).

Main Results:

  • KAP1 mediates the repression of IFN/STAT1 signaling.
  • Endogenous KAP1 and STAT1 were shown to associate in vivo.
  • siRNA-mediated knockdown of KAP1 enhanced IFN-induced STAT1-dependent IRF-1 gene expression.

Conclusions:

  • KAP1 acts as an endogenous repressor of the IFN/STAT1 signaling pathway.
  • KAP1's interaction with STAT1 is functionally significant for gene regulation.
  • Targeting KAP1 could modulate immune responses mediated by the IFN/STAT1 pathway.